The ESRD Compendium: An Evolving Resource for Renal Professionals

This chapter addresses multiple levels of renal replacement therapies (RRTs)¹²³⁴. It is about selecting the most appropriate mode of therapy site and type of dialysis access. The algorithms outlined in this module are designed to be simplistic and practical derived from a multilayered complex reality of systems in drift.   A lifelong strategy also includes prevention of progression of ESRD, considering several types of renal transplantation, mode of dialysis before it is needed, and type and site of dialysis access at the appropriate time. This needs much foresight into planning and preparation and teaching to prevent poor outcome⁷. Sadly, the status of affairs is far from reality. To achieve outcomes that are realistic requires true synergistic teamwork where cooperation and trust are key ingredients for success²³.

Much controversy surrounds the selection of the appropriate renal replacement therapy (RRT), including mode of dialysis, type and site of dialysis access, when to place and when to start dialysis and who places the access. This conundrum is reflected by the wide geographical variation in how renal replacement therapy strategies are applied⁶.

The choices between dialysis modalities are remarkably varied around the globe influenced by team skills, cooperation between specialties, socioeconomic, governments mandate to mention a few⁶.  While PD is the prevalent dialysis mode in about 12 % in the United States, 11% in Italy, and 3 % in Japan, it is almost 50% in Hong Kong by government mandate. Factors influencing dialysis modality selection include patient desire, lifestyle, education, and most of all, comorbidities. Team skills, interactions and cooperation between specialties are crucial²³.

Selection of the appropriate dialysis access is a key component in maximizing ideal outcomes. All things considered, renal transplantation is the bets replacement of the dialysis machine. However, the proportion of patients on dialysis transplants is low (less than 3% / year) because of lack of qualification mostly related to multiple co-morbidities. Thus, most patients with ESRD depend upon various dialysis modalities for sustaining life. The algorithm and strategies outline decision-making processes based on many multilayered factors⁷. The intention is to have universal applications driven by the spirit of the mission statement of “Doing Things the Right Way”².  Philosophically, this approach implies that while striving for the best practice option for each patient, the actual treatment modality may be quite different depending on a complex set of circumstances.

Factors favoring PD include lack of vasculature suitable for native vein AVF.  Other medical factors include heparin intolerance. The well-informed patient and family will opt for PD in 30-50 % of cases. PD provides more personal freedom and autonomy, as it is performed by the patient at home. Patients can remain in the workforce and travel, as dialysis can be performed during nighttime. PD is less costly to society, a kidney transplant while on PD has less early dysfunction, there are no needle punctures, and few blood borne infections associated with PD.

Benefits from reading and understanding dialysis coding maximize financial reimbursement, while eliminating potential jailtime for fraudulent billing. ESRD patients generate high procedure volumes and complex claims across several service hospital outpatient lines making dialysis access a prime target for payer scrutiny and enforcement.  For each $1.00 the Department of Justice invests in fraud cases, they return an average of $5.59 back to the government. As these procedures have high reimbursement rates, the return on investment for an access case is better than other procedures. In recent years, most of the cases involving dialysis access have been Qui Tam (whistleblower) cases, and the publicity surrounding these cases is sometimes enticing to providers looking to blow the whistle on either a previous employer or competitor.

Current trends amplify the stakes are that ESRD patients constitute a small fraction of beneficiaries but consume a large share of Medicare spending. Dialysis access interventions (angioplasty, thrombectomy, stent placement, surgical revision and new innovative procedures) are high-cost and frequently repeated procedures.

Home dialysis is a treatment for kidney failure that lets you dialyze at home with many benefits, including flexible treatment, a less restrictive diet and improved health outcomes. The two main types of home dialysis are hemodialysis and peritoneal PD with about 3% and 12 %, respectively in the United States. Home Peritoneal dialysis (PD) is a needle-free treatment that can be performed at home during the day or even at night while sleeping.

Physical examination (PE) is basic to all fields of medicine. Unfortunately, in many instances, it has been replaced by more elaborate and costly technical approaches to diagnosis. In the evaluation of the hemodialysis access, PE remains indispensable in diagnosing problems and making decisions concerning management. PE is easily learned and performed, inexpensive to apply, and provides instant information with a high level of accuracy, especially in the cases of the native vein fistulas (AVF). To the physician dealing with dialysis access, PE is a mandatory skill.

As a lifelong access utilization strategy, peritoneal dialysis should be considered as the first dialysis modality in suitable cases, followed by appropriately planned hemodialysis. Duplex Doppler Ultrasonography Examination (DDU) is the logical step following history and PE for pre-operative vascular mapping in determining the optimal hemodialysis access type and site. DDU will also assess and diagnose many vascular access problems and direct the proper surgical or endovascular decision for appropriate management. Most of the discussion of PE is based on AVF as it is more sensitive PE than arteriovenous graft (AVG). Most principles discussed are applicable to both. This chapter also has an extensive link to the use of Ultrasound in dialysis access.

A kidney transplant is the best replacement for the dialysis machine. A living donor is superior to diseased kidney donor. In some countries, deceased donations are either not available or are not legally allowed.

The donor pool is increased by using extended criteria for donors defined as donor age >60 years with 2 or more risk factors such as hypertension, renal impairment (creatinine >1.3 mg/dl) or death due to intracranial hemorrhage. With these less desirable organs, the outcomes are still better than in patients remaining on dialysis. How organs are allocated varies, with major differences in donation and transplantation rates between countries⁶.

Recently the use of genetically modified pigs has been used as kidney donors which has the future potential of unpredictable outcome of xenotransplantation²⁴.

The most common cause of kidney transplant loss is a patient dying with a functioning graft. The lifespan of a kidney transplant is unpredictable on an individual basis as it depends on both donor and recipient. The average lifespan of a kidney is >15 years when all transplants are considered, but it covers a wide range with some patients retaining function after 40 years while others fail within the 1st year.

The transplant team is best visualized with the patient in the center¹²³⁴⁵⁶. The team comprises transplant surgeons, transplant nephrologists, referring physicians, transplant coordinators, the hospital transplant unit, dietitians, psychologists, the operating room, histocompatibility laboratory, hospital administration, the organ procurement organization and other ancillary facilities. The outpatient clinic, home care services and social workers may also be required. The optimal outcome of a transplant is not only survival but also returning the patient to an active and a normal life. To do this and to achieve long-term success of a transplant, the multidisciplinary team must work together, with each team member clear on their specific role to ensure continuity of care.

As in complex systems¹⁷, the use of protocols allows monitoring of outcomes and the ability to audit and adapt. Because of the complexity of the transplant process, it is essential to have protocols, checklists, standardized procedures and clinical practice guidelines to ensure patient safety and maintain good outcomes in an efficient and cost-effective manner. Protocols and standard operating procedures reduce errors and facilitate early identification of complications or accidents; allowing the whole team to communicate, work effectively and synergistically and to progressively develop. The key features of success in such programs are trust and cooperation^1256723.

The well organized, efficient and safe transplant program can develop and grow as processes are measured and managed. The similarity to the airline industry is striking. Often, a series of errors or mishaps (miscommunications) lead to a single fatal decision or event, and, frequently, the responsibility rests on a single person. A successful transplant program is dependent on each member of the team performing their responsibilities without failing, as well as adhering to a system of checks and balances which keeps the entire team on track. Protocols must be continuously updated as medical knowledge and technology evolve. Successful development and implementation of protocols rest with a few key individuals. For example, what may be a routine process in one transplant center requires regular maintenance in others.

This chapter aims to engage the reader to realize we all have decisions to make that impact patients’ lives.The questions will have distinctive designs including short case history, videos, and images as appropriate.

Dialysis access care in end-stage renal disease (ESRD) represents a classic complex system problem: high comorbidity burden, multiple stakeholders, pronounced practice variation, and cumulative decision-making across patient lifespans¹². Paradoxically, ESRD is also uniquely suited for data-driven approaches because patients undergo frequent observation, typically three hemodialysis sessions weekly, generating dense longitudinal datasets amenable to computational analysis and real-time clinical feedback³⁴⁵⁶.

Artificial intelligence (AI) offers four evidence-supported applications in dialysis access. First, pre-procedure planning: machine learning models trained on registry data achieve area under the receiver operating characteristic curve (AUROC) of 0.90 for predicting 1-year arteriovenous (AV) access success, substantially outperforming traditional logistic regression (AUROC 0.70) and enabling patient-centered access type and site selection within a comprehensive KDOQI ESRD Life Plan framework²⁵²⁶. Second, early post-creation assessment: point-of-care machine learning tools integrating ultrasound parameters with clinical variables (AUROC 0.78–0.81) can complement physical examination in predicting cannulation readiness and identifying patients requiring targeted salvage interventions²⁶. Third, surveillance and triage: deep learning analysis of blood flow sounds using vision transformers achieves stenosis screening performance comparable to nephrologist physical examination while enabling scalable, automated monitoring²⁷²⁹. Fourth, intradialytic safety: recurrent neural network models analyzing hemodialysis session data achieve AUROC 0.94 for real-time prediction of intradialytic hypotension, enabling preemptive prescription adjustments²⁹³⁰.

Despite momentum, systematic review confirms that most vascular access AI evidence remains retrospective, single-center, and methodologically vulnerable to bias, label noise, and limited external validation—mandating prospective evaluation, rigorous calibration, and human-in-the-loop deployment before clinical adoption³¹. Consistent with the KidneyAcademy mission, this chapter delineates where AI demonstrates implementation readiness versus where it remains investigational, and how to deploy these tools in ways that strengthen—rather than supplant—structured clinical reasoning¹⁷. This chapter functions as a living resource with linked multimedia content and pre/post self-assessment questions to reinforce applied learning.

Physicians providing dialysis access for patients receiving maintenance dialysis routinely rely on a broad spectrum of medical devices, including catheters, grafts, balloons, stents, and evolving access technologies. Despite this dependence, formal education on medical device regulation remains limited in clinical training. Gaps in regulatory literacy can contribute to misinterpretation of device claims, inappropriate off-label use, delayed recognition of safety signals, and misalignment between clinical practice, institutional governance, and reimbursement paradigms.

The Objective is to develop a concise, clinician-focused educational module that equips vascular surgeons, nephrologists, and interventional radiologists with a working understanding of U.S. medical device regulation as it applies specifically to hemodialysis vascular access care.

The web-based Curriculum is Designed to deliver a structured overview of device regulation grounded in real-world clinical decision-making. Content will be organized around these essential domains:

1. regulatory system fundamentals, including the distinct roles of the U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services;
2. device classification and risk stratification;
3. FDA market entry pathways (510(k), De Novo, PMA);
4. device labeling, indications, and off-label use;
5. clinical evidence standards for vascular access devices;
6. post-market surveillance and physician adverse event reporting;
7. recalls and safety communications;
8. regulatory implications of device modifications and iterative innovation;
9. the interface between regulation and reimbursement;
10. ethical and conflict-of-interest considerations in physician–industry interactions, and FDA resources to assist safe use of the devices employed in practice.

This chapter emphasizes the practical educational approach knowledge rather than regulatory theory, using device-specific examples, case-based scenarios, and by citing common pitfalls encountered in dialysis access practice.

After reading the participants will be able to distinguish regulatory clearance from reimbursement coverage, critically assess device claims and evidence, recognize medico-legal boundaries of device use, and respond appropriately to post-market safety information. The curriculum aims to improve patient safety, support informed technology adoption, and enhance physician engagement with institutional and regulatory processes affecting dialysis access care.

It is concluded that targeted education in medical device regulation represents a critical yet underdeveloped component of competency for clinicians caring for patients with end stage kidney disease. This chapter provides a framework to bridge that gap and align clinical practice with regulatory, ethical, and economic realities.